Guided Therapeutics Inc (GTHP)
GTHP moved a median of 0.00% 30 minutes after news, and 0.00% by the close. How GTHP actually reacts to news — the realized, point-in-time move the market made, measured across 69 labeled events over the last three years with zero look-ahead.
GTHP’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 22% | 45 |
| 30-min | 0.00% | 27% | 49 |
| 60-min | 0.00% | 38% | 50 |
| to close | 0.00% | 45% | 60 |
| Middle 50% of GTHP reactions | 0.00% to +0.67% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 69 |
Half of all Guided Therapeutics Inc news events land between +0.00% and +0.67% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when GTHP moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to GTHP's baseline. Nothing else.
Recent GTHP events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Guided Therapeutics Reaches Collaborative Agreement with Türkiye’s Ministry of Health to Become Primary Screening Test for Cervical Cancer | Press release | Business Wire | +0.00% | +25.00% | |
| Form 10-Q GUIDED THERAPEUTICS INC For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +20.78% | +20.78% | |
| Guided Therapeutics Receives $80,000 Payment as Fourth Installment of $700,000 Purchase Order with Chinese Distributor | Press release | Business Wire | +0.00% | +0.00% | |
| Guided Therapeutics Announces New Agreement with Distribution Partner Yuanshuo Medical Instruments Corporation | Press release | Business Wire | +0.00% | -6.67% | |
| Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA | Press release | Business Wire | +0.00% | +10.22% | |
| Form 10-Q GUIDED THERAPEUTICS INC For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | — | — | |
| Form 10-K GUIDED THERAPEUTICS INC For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -19.31% | -6.69% | |
| Guided Therapeutics Provides Updates on FDA Application Study Results, 2025 Earnings Increase and Successful Warrant Offering | Press release | Business Wire | -19.31% | -6.69% | |
| Form 8-K GUIDED THERAPEUTICS INC For: Mar 02 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.00% | |
| Analysis of Guided Therapeutics' FDA Study Data Reveals Compelling Clinical Need for LuViva | Press release | Business Wire | +1.63% | +28.05% | |
| Guided Therapeutics Receives $88,000 Payment as Third Installment of $700,000 Purchase Order with Chinese Distributor | Press release | Business Wire | +0.00% | +0.00% | |
| Guided Therapeutics Inks Initial $200,000 Deal with New Distribution Partner Yuanshuo Medical Instruments Corporation | Press release | Business Wire | +0.00% | +2.08% | |
| Guided Therapeutics Receives $70,000 -- Its Second of Nine Payments Totaling $700,000 -- from New Chinese Distribution Partner that Provides Products for 2 Million Annual Cervical Cancer Screenings | Press release | Business Wire | +0.00% | — | |
| Form 10-Q GUIDED THERAPEUTICS INC For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | — | +0.00% | |
| Guided Therapeutics Provides Update on Completion of US FDA Clinical Trial | Press release | Business Wire | +0.00% | +0.52% | |
| Guided Therapeutics Makes Initial Shipment to New Chinese Distribution Partner Hangzhou Dongye Medical Technology, Ltd. | Press release | Business Wire | +0.00% | +32.75% | |
| Guided Therapeutics Receives $700,000 Purchase Order and Initial Payment from New Chinese Distributor | Press release | Business Wire | +5.12% | +5.42% | |
| Guided Therapeutics Receives $100,000 from SMI’s Investment Partners to Continue Commercialization Process of LuViva in China | Press release | Business Wire | +0.00% | +0.00% | |
| Form 10-Q GUIDED THERAPEUTICS INC For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +25.00% | |
| Form 10-K GUIDED THERAPEUTICS INC For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | — | — | |
| Form 8-K GUIDED THERAPEUTICS INC For: Dec 18 | SEC filing · Form 8-K | SEC EDGAR | +4.42% | -1.88% | |
| Guided Therapeutics Receives Order and Full Payment From Indonesia for 4 LuViva Systems and 1,200 Disposables | Press release | Business Wire | +0.72% | +0.00% | |
| Form 10-Q GUIDED THERAPEUTICS INC For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | — | +0.00% | |
| Guided Therapeutics Announces Filing of Application for NMPA Approval to Market and Sell LuViva in China | Press release | Business Wire | +0.00% | -1.51% | |
| Form 8-K GUIDED THERAPEUTICS INC For: Sep 23 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form 10-Q GUIDED THERAPEUTICS INC For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | — | — | |
| Guided Therapeutics’ Announces Data from Chinese NMPA Clinical Study Signed Off by All Four Clinical Sites With Better Than Expected Results | Press release | Business Wire | +0.67% | +0.67% | |
| Form 10-Q GUIDED THERAPEUTICS INC For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +52.89% | |
| Form 10-K GUIDED THERAPEUTICS INC For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.00% | +0.00% | |
| Leading Cervical Cancer Doctors Support Approval of LuViva in China Based on Preliminary Review of Clinical Trial Results | Press release | Business Wire | +0.00% | +0.00% | |
| Guided Therapeutics Announces Completion of Clinical Study for Chinese Regulatory Approval | Press release | Business Wire | — | -36.07% | |
| Form 10-Q GUIDED THERAPEUTICS INC For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | — | +0.00% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the GTHP section they belong to.
Where else GTHP is measured.
GTHP earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Psychemedics Corporation (PMD) | 70 | -0.43% | 28% |
| CANNABIX TECHS INC ORD (BLOZF) | 69 | +2.43% | 74% |
| INTELGENX TECHS CORP (IGXT) | 69 | +0.57% | 52% |
| MOTUS GI HOLDINGS INC (MOTS) | 69 | +0.87% | 55% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Guided Therapeutics Inc's median reaction calculated?
Every labeled GTHP news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 69 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 27% of GTHP's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does GTHP's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.